邦利品牌怎么样 申请店铺

我要投票 邦利在塑料橡胶制品行业中的票数:388 更新时间:2025-08-25
邦利是哪个国家的品牌?「邦利」是 安徽华能医用橡胶制品股份有限公司 旗下著名品牌。该品牌发源于安徽省巢湖市,由创始人何义文在2003-04-14期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力邦利品牌出海!将品牌入驻外推网,定制邦利品牌推广信息,可以显著提高邦利产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

邦利怎么样

安徽华能医用橡胶制品股份有限公司,成立于2003年4月,坐落在皖江经济带上的无为县姚沟工业区,公司占地面积80000㎡,建筑面积26000㎡,注册资金4200万元,是一个集药用丁基橡胶瓶塞、药用合成聚异戊二烯垫片科研、开发和生产为一体的企业。2015年3月6日,公司在新三板成功挂牌(证券名称:华能橡胶,证券代码:832037)。

公司内设部、室14个,现有员工200余人,其中管理人员30人,工程技术人员18人,拥有中、高级技术职称的有16人,专职检验人员24人。年可生产药用丁基橡胶抗生素胶塞、聚异戊二烯垫片、冻干剂胶塞、输液胶塞、血液和生物制品胶塞等系列产品30亿只。为员工的身体健康和用药安全,公司严格按照GMP规范和《中国药典》要求,建立了标准的洁净净化厂房,拥有空气洁净净化系统。购置了自动化、程序化程度较高的生产设备。组建了独立的产品质量检测中心,配置了齐全的各种检测仪器,具备了对原材料、辅助材料、半成品和产成品的各种性能的全过程质量检测。公司在对生产、检测设备及整体工艺布局上,充分考虑人流、物流的合理性和操作的方便性,使整个生产线完整、顺畅、紧凑。

挂牌后,公司将继续恪守“以人为本、科技为先,以质立业、诚信兴业”的经营理念,把品质专业化作为企业发展的基石,不断增强在技术、产品、质量、服务等方面的竞争优势,以优质的产品和至诚的服务来满足广大医药生产企业的需求,为我国医药事业向更高、更新的方向发展做出新的贡献。


Anhui Huaneng medical rubber products Co., Ltd., founded in April 2003, is located in YAOGOU Industrial Zone, Wuwei County, Wanjiang economic belt. The company covers an area of 800000 square meters, with a construction area of 26000 square meters and a registered capital of 42 million yuan. It is an enterprise integrating scientific research, development and production of medical butyl rubber bottle stopper and medical synthetic polyisoprene gasket. On March 6, 2015, the company was successfully listed on the new third board (Securities Name: Huaneng rubber, securities code: 832037). The company has 14 departments and offices, with more than 200 employees, including 30 management personnel, 18 engineering and technical personnel, 16 with medium and senior technical titles, and 24 full-time inspectors. It can produce 3 billion medical butyl rubber antibiotic stopper, polyisoprene gasket, freeze-drying agent stopper, infusion stopper, blood and biological product stopper, etc. For the health of employees and drug safety, the company has established a standard clean purification plant in strict accordance with GMP specifications and the requirements of Chinese Pharmacopoeia, and has an air clean purification system. We have purchased production equipment with high degree of automation and programming. An independent product quality testing center has been set up, equipped with a complete range of testing instruments, and equipped with the whole process quality testing of raw materials, auxiliary materials, semi-finished products and finished products. In terms of production and testing equipment and overall process layout, the company fully considers the rationality of people flow and logistics and the convenience of operation to make the whole production line complete, smooth and compact. After listing, the company will continue to adhere to the business philosophy of "people-oriented, science and technology first, quality based business, integrity based business", take quality specialization as the cornerstone of enterprise development, and constantly enhance its competitive advantages in technology, products, quality, service and other aspects, to meet the needs of the majority of pharmaceutical production enterprises with high-quality products and sincere services, so as to make the pharmaceutical industry in China to a higher level . make new contributions to the development of the updated direction.

本文链接: https://brand.waitui.com/f8943ebef.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

格林美:筹划发行H股股票并在香港联交所上市

36氪获悉,格林美发布公告,经充分研究论证,董事会同意公司发行H股股票并在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。公司将充分考虑现有股东的利益和境内外资本市场的情况,在股东会决议有效期内(即经公司股东会审议通过之日起24个月或同意延长的其他期限)选择适当的时机和发行窗口完成本次发行上市。截至目前,公司正积极与相关中介机构就本次发行上市的相关工作进行商讨,除本次董事会、监事会审议通过的相关议案外,其他关于本次发行上市的具体细节尚未最终确定。

9分钟前

中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元

36氪获悉,中信证券研报表示,创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求,改变前列腺癌诊疗范式,实现诊疗一体化,提高患者依从性和生存期。目前中国尚无任何RDC上市,市场呈现蓝海状态,海外前列腺癌RDC诊疗产品在2021年上市,2024年市场已接近30亿美元,充分验证了其巨大的商业价值。中信证券认为中国有望复刻海外前列腺癌RDC诊疗市场发展路径,预计未来中国前列腺癌RDC诊疗市场将超100亿元,市场呈现高速增长状态。该行业关键点为核素、配体分子形态、生产配送能力,建议关注在上述条件具有优势的公司。

9分钟前

​锡业股份:上半年净利润10.62亿元,同比增长32.76%

36氪获悉,锡业股份披露2025年半年报,上半年实现营业收入210.93亿元,同比增长12.35%;归属于上市公司股东的净利润10.62亿元,同比增长32.76%;基本每股收益0.626元。

9分钟前

亚世光电:上半年净利润538.04万元,同比下降36.21%

36氪获悉,亚世光电披露2025年半年报,上半年实现营业收入4.32亿元,同比增长30.01%;归属于上市公司股东的净利润538.04万元,同比下降36.21%;基本每股收益0.0331元。

9分钟前

金螳螂:上半年净利润3.58亿元,同比增长3.95%

36氪获悉,金螳螂披露2025年半年报,上半年实现营业收入95.28亿元,同比增长2.49%;归属于上市公司股东的净利润3.58亿元,同比增长3.95%;基本每股收益0.1348元。

10分钟前

本页详细列出关于邦利的品牌信息,含品牌所属公司介绍,邦利所处行业的品牌地位及优势。
咨询